Navigation Links
Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
Date:6/24/2013

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX4211, characterizations of the results of and projected timing of clinical trials of LX4211, and the potential therapeutic and commercial potential of LX4211.  This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Unless specifically indicated otherwise, results reported as trends were not statistically significant. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
2. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
3. Lexicon To Present At The Jefferies Global Healthcare Conference
4. Lexicon To Present At The Bank of America Merrill Lynch Healthcare Conference
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
6. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
7. Lexicon to Report First Quarter Financial Results on May 10, 2013
8. Lexicon To Present At The Needham Healthcare Conference
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
10. Lexicon To Present At The BIO CEO & Investor Conference
11. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "MEMS Gyroscopes Analog Devices ADIS16136 ... report to their offering. ... tactical grade applications made a lot of progress ... reliability. They are now accepted in high-reliability environments, ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ) has announced ... Filters - Global Trends, Estimates and Forecasts, 2012-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior Vena Cava (IVC) ... 2016. The North America accounts ... Europe claims approximately 27% (2018). ...
(Date:12/15/2014)... BerGenBio AS, a biopharmaceutical company ... cancers, today announces that it has raised NOK90 million ... and existing investors. BerGenBio will use the ... its pipeline of innovative cancer therapeutics, in particular an ... BGB324, a first-in-class selective Axl kinase inhibitor, which is ...
Breaking Medicine Technology:MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4BerGenBio Completes NOK90 Million Fundraising 2
... Aug. 17 Luminex Corporation (Nasdaq: LMNX ... it has donated the first commercial unit of its ... his scientific team at the Papua New Guinea Institute ... in Papua New Guinea to progress malaria research led ...
... Equinox Surgical Solutions LLC today announced ... designed and developed by a minimally invasive, Board Certified, ... and his team to improve patient and surgical team ... acquire, hand-off, dispose of and reload sutures with an ...
Cached Medicine Technology:Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research 2Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research 3Equinox Surgical Solutions Launches Flagship Product, SutureAssist® 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Ecosystem Assessment, scientists have said that degradation of the eco ... human health and may cause greater harm in next 50 ... to cause a major outbreak and new diseases are emerging ... system are being used in unsustainable way. ,The report ...
... and 799 non-diabetic women volunteers in the age group ... Center, Seattle, US had said that being diabetic increases ... women who have had their menopause. ,The researchers ... hemoglobin A1c, urine culture, residual bladder volume and diabetes ...
... into a data comprising of 5461 girls between 11 to ... makes these girls more prone to stress fractures. ,The ... vigorous physical activity, which often lasts for 16 or more ... risk of having a stress fracture than the girls doing ...
... that tumor necrosis factor (TNF)-á-blocking therapy used for ... ,The study done by the Dutch scientists ... Netherlands had taken into account the number and ... with the TNF-á-blocking therapy. 128 dermatological conditions in ...
... of University of Mississippi Medical Center US have found ... hypertension and high blood pressure. ,3216 people who ... subjected to 24 hr monitoring of systolic and diastolic ... to mean daytime and nighttime systolic and diastolic blood ...
... rats suggests that eating onions may be the key to ... have identified a compound in onions, a peptide called GPCS ... involved segregation of bone cells of newborn mice that were ... These cells were later exposed to the peptide GPCS. The ...
Cached Medicine News:
... Neonatal and Pediatric TRACH ... a multi access catheter ... lavage/irrigation port and locking ... sizes and packaging configurations. ...
... Stainless steel spiral reinforced. X-ray opaque. Super ... band. Single use. Adjustable Flange: The flange ... to suit the thickness of the cervical ... clockwise until the flange is tightly connected ...
... ULTRA® Suctionaid® tracheostomy tubes provide an additional ... from above the tracheostomy tube cuff. , ... tubes provide an additional lumen to permit ... tracheostomy tube cuff helping to reduce the ...
The soft silicone design promotes patient comfort. , ,Bivona® laryngectomy tubes feature a soft compliant silicone design for patient comfort....
Medicine Products: